Leonard C. Glass - Concepedia

Author

Leonard C. Glass

The University of Texas Health Science Center at San Antonio

Also Known As

L Glass, L. Glass, Leonard C Glass, Leonard C. Glass, Leonard Glass, Leonard C. Glass

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Eli Lilly (United States)Istituto di Fisiologia Clinica Texas Diabetes Institute Park Nicollet Clinic

About

Leonard C. Glass is an author at The University of Texas Health Science Center at San Antonio specializing in metabolic syndrome, diabetes, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.5K
2	Diabetes	7	7	1.5K
3	Health Sciences	6	6	1.4K
4	Biochemistry	1	1	274
5	Hepatology	1	1	84

Leonard C. Glass

Publications

Citations

H-Index

Page 1

	Year	Citations
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes Gregory Gaich, Jenny Y. Chien, Haoda Fu, Cell Metabolism ObesityMetabolic SyndromeHealth SciencesMetabolic DisorderMedicine	2013	867
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes John B. Buse, Richard M. Bergenstal, Leonard C. Glass, Annals of Internal Medicine	2011	503
Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda, Diabetes Care	2001	404
Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients Mandeep Bajaj, Swangjit Suraamornkul, Paul K. Piper, The Journal of Clinical Endocrinology & Metabolism	2004	356
Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes Mandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr, Diabetes	2003	291
Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients Y. Miyazaki, Leonard C. Glass, Curtis Triplitt, Diabetologia ObesityMetabolic SyndromeBiochemistryLipid NutritionMedicine	2001	274
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus Yoshinori Miyazaki, Leonard C. Glass, Curtis Triplitt, American Journal of Physiology-Endocrinology and Metabolism	2002	255
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Louis J. Aronne, Deborah B. Horn, Carel W. le Roux, New England Journal of Medicine	2025	250
Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus Mandeep Bajaj, Swangjit Suraamornkul, L. Jean Hardies, Diabetologia Metabolic SyndromeDiabetes ManagementMedicinePhysiologyDiabetes	2007	136
Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes Caroline M. Apovian, Richard M. Bergenstal, Robert Cuddihy, The American Journal of Medicine ObesityMetabolic SyndromeDiabetes ManagementLifestyle ModificationDiabetes	2010	126

Page 1